GB9407386D0
(en)
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
DE19821625C1
(de)
*
|
1998-05-15 |
2000-01-05 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
EP1005863A1
(de)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
US7250176B1
(en)
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6294199B1
(en)
*
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
EP1064937A1
(de)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
|
WO2001013901A2
(en)
*
|
1999-08-20 |
2001-03-01 |
Ferrosan A/S |
A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress
|
AU783656B2
(en)
*
|
1999-09-02 |
2005-11-24 |
Nostrum Pharmaceuticals, Inc. |
Controlled release oral dosage suitable for oral administration
|
DE60043447D1
(de)
*
|
1999-09-28 |
2010-01-14 |
Panacea Biotec Ltd |
Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
|
EP1138330A1
(de)
*
|
1999-12-23 |
2001-10-04 |
Warner-Lambert Company |
Kombinationsarzneimittel enthaltend Trimebutin und ein Opiatanalgetikum
|
BR0007360A
(pt)
*
|
1999-12-23 |
2001-08-14 |
Johnson & Johnson |
Composição de liberação controlada
|
WO2001056544A2
(en)
|
2000-02-04 |
2001-08-09 |
Depomed, Inc. |
Shell-and-core dosage form approaching zero-order drug release
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
US20070141107A1
(en)
*
|
2000-03-15 |
2007-06-21 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
US6372252B1
(en)
*
|
2000-04-28 |
2002-04-16 |
Adams Laboratories, Inc. |
Guaifenesin sustained release formulation and tablets
|
AU2001292185A1
(en)
|
2000-10-12 |
2002-04-22 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
DE60103299T2
(de)
*
|
2000-10-30 |
2005-05-12 |
Lupin Ltd., Mumbai |
Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
|
KR100778835B1
(ko)
*
|
2000-12-28 |
2007-11-22 |
엘지.필립스 엘시디 주식회사 |
액정표시장치의 제조방법
|
KR100685945B1
(ko)
|
2000-12-29 |
2007-02-23 |
엘지.필립스 엘시디 주식회사 |
액정표시장치 및 그 제조방법
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
US20030032675A1
(en)
*
|
2001-02-15 |
2003-02-13 |
Franz G. Andrew |
Manufacture of thyroid hormone tablets having consistent active moiety amounts
|
JP2004525109A
(ja)
*
|
2001-02-15 |
2004-08-19 |
キング・ファーマシューティカルズ・インコーポレイティッド |
安定化された甲状腺ホルモン医薬組成物、及びその製法
|
US20030224047A1
(en)
*
|
2001-02-15 |
2003-12-04 |
Franz G. Andrew |
Levothyroxine compositions and methods
|
EP2311440A1
(de)
*
|
2001-04-05 |
2011-04-20 |
Collagenex Pharmaceuticals, Inc. |
Gesteuerte Freigabe von Tetracyclinverbindungen und Tetracyclinderivaten
|
CA2343949A1
(en)
*
|
2001-04-12 |
2002-10-12 |
Bernard Charles Sherman |
Benazepril hydrochloride tablet formulations
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
GB0114069D0
(en)
*
|
2001-06-08 |
2001-08-01 |
Smithkline Beecham Plc |
Composition
|
US20030190349A1
(en)
*
|
2001-08-10 |
2003-10-09 |
Franz G. Andrew |
Methods of stabilizing pharmaceutical compositions
|
US20030180353A1
(en)
*
|
2001-08-10 |
2003-09-25 |
Franz G. Andrew |
Stabilized pharmaceutical compositions
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
US20030198667A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz Andrew G. |
Methods of producing dispersible pharmaceutical compositions
|
US20030203967A1
(en)
*
|
2001-08-14 |
2003-10-30 |
Franz G. Andrew |
Levothyroxine compositions having unique Tmax properties
|
US20030199586A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Unique levothyroxine aqueous materials
|
US20030195253A1
(en)
*
|
2001-08-14 |
2003-10-16 |
Franz G. Andrew |
Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030198672A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique triidothyronine plasma AUC properties
|
US20030180356A1
(en)
*
|
2001-10-29 |
2003-09-25 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
US20030099699A1
(en)
*
|
2001-11-13 |
2003-05-29 |
Hanshew Dwight D. |
Storage stable thyroxine active drug formulations and methods for their production
|
US6645526B2
(en)
*
|
2001-11-13 |
2003-11-11 |
Mylan Pharmaceuticals, Inc. |
Storage stable thyroxine active drug formulations and methods for their production
|
US6863901B2
(en)
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US7229644B2
(en)
*
|
2002-05-23 |
2007-06-12 |
Cephalon, Inc. |
Pharmaceutical formulations of modafinil
|
US8911781B2
(en)
|
2002-06-17 |
2014-12-16 |
Inventia Healthcare Private Limited |
Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
|
PA8578501A1
(es)
|
2002-07-25 |
2005-02-04 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
AR040588A1
(es)
*
|
2002-07-26 |
2005-04-13 |
Schering Corp |
Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
|
US20040116532A1
(en)
*
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
KR20050053677A
(ko)
*
|
2002-09-20 |
2005-06-08 |
안드렉스 랩스 엘엘씨 |
비구아나이드와 티아졸리디네디온 유도체를 함유한 약제학적 투여형태
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
MXPA02010828A
(es)
*
|
2002-11-04 |
2004-07-16 |
Leopoldo Espinosa Abdala |
Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
SI1575566T1
(sl)
*
|
2002-12-26 |
2012-08-31 |
Pozen Inc |
Veäśplastna dozirna oblika vsebujoäśa naproksen in triptane
|
TWI355276B
(en)
*
|
2003-01-14 |
2012-01-01 |
Akira Tsuji |
Gastrointestinal absorption enhancer mediated by p
|
WO2004064815A1
(en)
*
|
2003-01-21 |
2004-08-05 |
Smartrix Technologies Inc. |
Oral dosage formulation
|
CA2515641A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
FR2851734B1
(fr)
*
|
2003-02-28 |
2006-06-09 |
Galenix Innovations |
Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
|
NZ542303A
(en)
*
|
2003-03-14 |
2008-12-24 |
Nirmal Mulye |
A process for preparing sustained release tablets
|
US20040192781A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Haley Eugene T. |
Method of administration for metoclopramide and pharmaceutical formulation therefor
|
PL1615622T3
(pl)
*
|
2003-04-07 |
2012-12-31 |
Supernus Pharmaceuticals Inc |
Preparaty doksycyklin do jednorazowego dziennego podawania
|
US20050013863A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
US6863830B1
(en)
*
|
2003-08-21 |
2005-03-08 |
Biolab Services, Inc. |
Dual layer tablet, method of making and use thereof
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050118267A1
(en)
*
|
2003-09-19 |
2005-06-02 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
EP1708684A2
(de)
|
2003-09-26 |
2006-10-11 |
Alza Corporation |
Arzneimittelbeschichtung mit hoher arzneimittelbeladung und verfahren dafür
|
US20050089570A1
(en)
*
|
2003-09-26 |
2005-04-28 |
Evangeline Cruz |
Oros push-stick for controlled delivery of active agents
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US20050084531A1
(en)
*
|
2003-10-16 |
2005-04-21 |
Jatin Desai |
Tablet with aqueous-based sustained release coating
|
EP1715852A2
(de)
*
|
2004-01-06 |
2006-11-02 |
Panacea Biotec Ltd. |
Nichtzerfallende feste zusammensetzung hochdosierter wasserlöslicher arzneistoffe zur oralen anwendung
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
WO2005099672A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
ES2308065T3
(es)
*
|
2004-04-30 |
2008-12-01 |
Topotarget Germany Ag |
Formulacion que comprende un inhibidor de histona desacetilasa, que exhibe una liberacion bifasica.
|
FR2873113B1
(fr)
*
|
2004-07-19 |
2007-06-15 |
Eurotab Sa |
Produit solide compacte bicouche de purification d'eau
|
US20060020007A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Roger Berlin |
Compositions containing policosanol and biotin and their pharmaceutical uses
|
KR101406767B1
(ko)
*
|
2004-08-13 |
2014-06-20 |
베링거 인겔하임 인터내셔날 게엠베하 |
프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출성 정제 제형, 이의 제조방법 및 이의용도
|
EP1786404A2
(de)
|
2004-09-01 |
2007-05-23 |
Euro-Celtique S.A. |
Opioid-dosierformen mit steady-state-cave proportional zur dosierung und auc und einzeldosen-cmax geringer als proportional zur dosierung
|
US20070129402A1
(en)
*
|
2004-12-27 |
2007-06-07 |
Eisai Research Institute |
Sustained release formulations
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
US8481565B2
(en)
*
|
2004-12-27 |
2013-07-09 |
Eisai R&D Management Co., Ltd. |
Method for stabilizing anti-dementia drug
|
US20060280789A1
(en)
*
|
2004-12-27 |
2006-12-14 |
Eisai Research Institute |
Sustained release formulations
|
JP2008528607A
(ja)
*
|
2005-01-26 |
2008-07-31 |
エラン・ファルマ・インターナショナル・リミテッド |
抗精神薬を含む制御調節組成物
|
DE102005019458A1
(de)
*
|
2005-04-25 |
2006-10-26 |
Grünenthal GmbH |
Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
|
WO2006118265A1
(ja)
*
|
2005-04-28 |
2006-11-09 |
Eisai R & D Management Co., Ltd. |
抗痴呆薬を含有する組成物
|
DE602006016785D1
(de)
*
|
2005-05-24 |
2010-10-21 |
Flamel Tech Sa |
Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung
|
US20070020333A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Chin-Chih Chiang |
Controlled release of hypnotic agents
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
JP5269595B2
(ja)
*
|
2005-09-09 |
2013-08-21 |
アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー |
1日1回投与用トラゾドン組成物
|
CA2620018A1
(en)
*
|
2005-09-28 |
2007-04-12 |
Mali Kadosh |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
DE102005048293A1
(de)
*
|
2005-10-08 |
2007-04-12 |
Sanofi-Aventis Deutschland Gmbh |
Retardformulierung für Pralnacasan
|
CA2629740A1
(en)
*
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
WO2007073702A2
(es)
|
2005-12-29 |
2007-07-05 |
Osmotica Corp. |
Comprimido multicapa con combinación de triple liberación
|
CZ300698B6
(cs)
*
|
2006-06-16 |
2009-07-22 |
Zentiva, A. S. |
Tableta s obsahem metforminu
|
FR2906801B1
(fr)
*
|
2006-10-05 |
2008-12-12 |
Eurotab Sa |
Produit solide compacte bicouche de potabilisaton d'eau et procede de preparation.
|
US8642083B2
(en)
|
2006-10-30 |
2014-02-04 |
Hanall Biopharma Co., Ltd. |
Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
|
US8394845B2
(en)
|
2006-10-30 |
2013-03-12 |
Hanall Biopharma Co., Ltd. |
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
|
US20080207593A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Collegium Pharmaceutical, Inc. |
Antihistamine Combination
|
US20100098757A1
(en)
*
|
2007-03-15 |
2010-04-22 |
Toyo Boseki Kabushiki Kaisha |
Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
|
US20110020408A1
(en)
*
|
2007-05-17 |
2011-01-27 |
Ranbaxy Laboratories Limited |
multilayered modified release formulation comprising amoxicillin and clavulanate
|
KR20100020459A
(ko)
|
2007-06-08 |
2010-02-22 |
아드레넥스 파마슈티컬스, 아이엔씨. |
지연 방출형 제제 및 아드레날린 조절부전의 치료방법
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
US8404275B2
(en)
*
|
2007-07-01 |
2013-03-26 |
Vitalis Llc |
Combination tablet with chewable outer layer
|
WO2009024858A1
(en)
*
|
2007-08-22 |
2009-02-26 |
Aurobindo Pharma Limited |
Controlled release dosage form of galantamine
|
ES2541809T3
(es)
*
|
2007-10-16 |
2015-07-24 |
Paladin Labs Inc. |
Composición bicapa para la liberación sostenida de acetaminofeno y tramadol
|
AU2008338207A1
(en)
|
2007-12-17 |
2009-06-25 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
FR2927965B1
(fr)
*
|
2008-02-22 |
2010-06-04 |
Valeo Materiaux De Friction Sa |
Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
|
WO2009154810A2
(en)
*
|
2008-02-25 |
2009-12-23 |
Dr. Reddy's Laboratories Ltd. |
Delivery systems for multiple active agents
|
WO2009118764A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Pharmaceutical composition comprising diclofenac and paracetamol
|
JP2009256237A
(ja)
*
|
2008-04-16 |
2009-11-05 |
Daiichi Sankyo Healthcare Co Ltd |
固形製剤
|
MX340249B
(es)
|
2008-08-15 |
2016-07-01 |
Depomed Inc |
Composiciones farmacéuticas retentivas gástricas para tratamiento y prevención de transtornos del sistema nervioso central (cns).
|
EA201100313A1
(ru)
|
2008-09-09 |
2011-10-31 |
Астразенека Аб |
Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
|
WO2010045656A2
(en)
*
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
WO2010053337A2
(ko)
*
|
2008-11-10 |
2010-05-14 |
(주)아모레퍼시픽 |
서방성 미립자 및 이의 제조방법
|
ES2509497T3
(es)
*
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
SG173058A1
(en)
*
|
2009-01-23 |
2011-08-29 |
Hoffmann La Roche |
Pharmaceutical composition comprising aleglitazar
|
KR101050076B1
(ko)
*
|
2009-02-04 |
2011-07-19 |
한국유나이티드제약 주식회사 |
제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
|
US20120064159A1
(en)
*
|
2009-05-28 |
2012-03-15 |
Aptapharma, Inc. |
Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
|
WO2010151697A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
AU2010263304A1
(en)
|
2009-06-25 |
2012-02-02 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an NSAID-associated ulcer
|
EP2506709B2
(de)
|
2009-12-02 |
2019-10-09 |
Adamas Pharmaceuticals, Inc. |
Amantadinzusammensetzungen und verfahren zu ihrer verwendung
|
EP2521537A2
(de)
|
2010-01-04 |
2012-11-14 |
Wockhardt Limited |
Pharmazeutische zusammensetzung zur modifizierten freisetzung von wirkstoffen
|
EP2394644B1
(de)
*
|
2010-05-04 |
2014-07-09 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Trimetazidin-Formulierung mit unterschiedlichen Freisetzungsprofilen
|
BR112012032816A2
(pt)
|
2010-06-22 |
2016-11-08 |
Twi Pharmaceuticals |
composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz
|
CN102727496A
(zh)
*
|
2011-04-12 |
2012-10-17 |
上海双健现代药物技术咨询有限公司 |
一种复方抗结核药口服固体制剂及其制备方法
|
US9226891B2
(en)
|
2011-10-28 |
2016-01-05 |
Vitalis Llc |
Anti-flush compositions
|
WO2013101897A2
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
ES2558204T3
(es)
*
|
2012-01-31 |
2016-02-02 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Formulaciones de comprimido bicapa de flurbiprofeno y glucosamina
|
US20150017242A1
(en)
*
|
2012-02-20 |
2015-01-15 |
Lupin Limited |
Bilayer Tablet of Dronedarone
|
PT3326611T
(pt)
|
2012-02-22 |
2020-08-20 |
Duchesnay Inc |
Formulação de doxilamina e piridoxina e/ou seus metabolitos ou sais
|
US20140072671A1
(en)
*
|
2012-06-29 |
2014-03-13 |
Adam Auerbach |
Multi-component oral delivery systems and uses thereof
|
HUE051406T2
(hu)
|
2012-11-14 |
2021-03-01 |
Grace W R & Co |
Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
|
WO2014075155A1
(pt)
*
|
2012-11-14 |
2014-05-22 |
Diffucap Chemobras Química E Farmacêutica Ltda |
Combinação farmacêutica contendo agente analgésico e agente antiespasmódico
|
RU2521572C1
(ru)
*
|
2012-12-21 |
2014-06-27 |
Федеральное государственное бюджетное учреждение науки Институт химии растворов им. Г.А. Крестова Российской академии наук (ИХР РАН) |
Сокристаллическая форма фенбуфена
|
KR20150126383A
(ko)
*
|
2013-03-12 |
2015-11-11 |
바이오히트 오와이제이 |
위장관 내의 알데하이드에 결합하는 경구 투여용 조성물
|
SI2991914T1
(en)
|
2013-04-29 |
2018-06-29 |
Clariant Healthcare Packagning (France) S.A.S. |
Dish cover
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
US9452181B2
(en)
|
2013-07-22 |
2016-09-27 |
Duchesnay Inc. |
Composition for the management of nausea and vomiting
|
WO2015010194A1
(en)
|
2013-07-22 |
2015-01-29 |
Duchesnay Inc. |
Composition for the management of nausea and vomiting
|
WO2015027303A1
(pt)
*
|
2013-08-28 |
2015-03-05 |
Diffucap Chemobras Quimica E Farmaceutica Ltda |
Procedimento. de fabricação de combinação farmacêutica contendo agente analgésico e agente antiespasmódico e combinação farmacêutica
|
WO2015063669A1
(en)
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
|
TWI595874B
(zh)
*
|
2014-08-29 |
2017-08-21 |
達契斯奈股份有限公司 |
多西拉敏及吡哆醇及/或其代謝產物或鹽之多模式釋放調配物
|
MY196073A
(en)
*
|
2014-08-29 |
2023-03-13 |
Duchesnay Inc |
Plurimodal Release Formulation of Doxylamine and Pyridoxine and/or Metabolites or Salts Thereof
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
CA2936748C
(en)
*
|
2014-10-31 |
2017-08-08 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US10413403B2
(en)
*
|
2015-07-14 |
2019-09-17 |
Boston Scientific Scimed, Inc. |
Prosthetic heart valve including self-reinforced composite leaflets
|
CA2993597A1
(en)
*
|
2015-07-23 |
2017-01-26 |
Athena Drug Delivery Solutions Pvt Ltd. |
Zolpidem composition and process for preparing the same
|
CA3072764A1
(en)
|
2017-08-24 |
2019-02-28 |
Adamas Pharma, Llc |
Amantadine compositions, preparations thereof, and methods of use
|
KR20200045496A
(ko)
|
2017-08-29 |
2020-05-04 |
콘리그 파마 에이피에스 |
수플라타스트 토실레이트를 포함하는 조성물
|
CN114845704A
(zh)
*
|
2019-12-19 |
2022-08-02 |
赛特瑞恩股份有限公司 |
包含西苯唑啉或其盐的药物制剂
|
CN114432300B
(zh)
*
|
2022-02-16 |
2023-08-01 |
平顶山市第二人民医院 |
含有比索洛尔和依那普利的药物组合物及其工艺
|